Insider Transactions in Q2 2023 at Jounce Therapeutics, Inc. (JNCE)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 03
2023
|
Tang Kevin C Director |
BUY
Other acquisition or disposition
|
Indirect |
10,000
+50.0%
|
$97,370,000
$9737.7 P/Share
|
|
May 03
2023
|
Tang Kevin C Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
5,300,087
-100.0%
|
$5,300,087
$1.85 P/Share
|
|
May 03
2023
|
Concentra Biosciences, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
10,000
+50.0%
|
$97,370,000
$9737.7 P/Share
|
|
May 03
2023
|
Perry A Karsen Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
5,000
-100.0%
|
-
|
|
May 03
2023
|
Richard /Ca/ Murray Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
188,778
-100.0%
|
-
|
|
May 03
2023
|
Kimberlee C Drapkin President, CFO and Treasurer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
66,018
-69.5%
|
-
|
|
May 03
2023
|
Robert Kamen Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
33,875
-100.0%
|
-
|
|
May 03
2023
|
Robert Kamen Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
60,975
-100.0%
|
-
|
|
Apr 04
2023
|
Richard /Ca/ Murray Director |
SELL
Open market or private sale
|
Direct |
39,228
-17.2%
|
$39,228
$1.85 P/Share
|